Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis

• Autores principales: Junru Chen (Autor), Yaowen Zhang (Autor), Xingming Zhang (Autor), Jinge Zhao (Autor), Yuchao Ni (Autor), Sha Zhu (Autor), Ben He (Autor), Jindong Dai (Autor), Zhipeng Wang (Autor), Zilin Wang (Autor), Jiayu Liang (Autor), Xudong Zhu (Autor), Pengfei Shen (Autor), Hao Zeng (Autor), Guangxi Sun (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Lacking head-to-head trial, the optimal treatment for patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel failure is unclear. This study is to compare the efficacy and safety of systemic treatments in patients who progressed after docetaxel to aid clinic...